Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 74361

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 18, 2016
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Attix Pharmaceuticals Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

D-1047-2016
Recall number
D-1047-2016
Initiated
May 18, 2016
Classification
Class III
Status
Terminated
Recalling firm
Attix Pharmaceuticals Inc
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP deviation

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

Code information

Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017

Distribution pattern

CO